<DOC>
	<DOC>NCT01393678</DOC>
	<brief_summary>The drug in this study is combined product of biphenyl dimethyl dicarboxylate (DDB) and garlic oil. This components showed synergistic enhancing effects in previous tests. In phase 2 test, 6 cap three times a day dosage (2cap T.I.D) is better than other dosage. Based on above, this study is phase 3 test to prove efficacy and safety of PENNEL.</brief_summary>
	<brief_title>Study to Evaluate Efficacy and Safety of PENNEL Capsule in the Patients With Chronic Liver Disease</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>7,7'-dimethoxy-(4,4'-bi-1,3-benzodioxole)-5,5'-dicarboxylic acid dimethyl ester</mesh_term>
	<criteria>Patients diagnosed with chronic hepatitis by biopsy Patients over 20, under 65 years of age. Patients with abnormal transaminase value. Pregnant and lactating women. Patients who have any history of esophageal bleeding, hepatic encephalopathy, ascites. Diabetes, thyroid dysfunction, fatty liver, liver cancer patients. Toxic hepatitis, alcoholic hepatitis. Total bilirubin value more than 3.0 mg/dl. Albumin value less than 3.0 g/dl. Patients who participating in other study about drug.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>